Human papillomavirus type 11 (HPV-11) neutralizing antibodies in the serum and genital mucosal secretions of African green monkeys immunized with HPV-11 virus-like particles expressed in yeast

Journal of Infectious Diseases

Volumn 176, Issue 5, 1997, Pages 1141-1145

  Lowe, Robert S ^b   Brown, Darron R ^b   Bryan, Janine T ^b   Cook, James C ^b   George, Hugh A ^b   Hofmann, Kathryn J ^b   Hurni, William M ^b   Joyce, Joseph G ^b   Dale Lehman, E ^b   Markus, Henry Z ^b   Neeper, Michael P ^b   Schultz, Loren D ^b   Shaw, Alan R ^b   Jansen, Kathrin U ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; IMMUNIZATION; MONKEY; NONHUMAN; PRIORITY JOURNAL; TISSUE CULTURE; UTERINE CERVIX; VIRUS CAPSID; VIRUS EXPRESSION; VIRUS INFECTION; VIRUS PARTICLE; WART VIRUS; YEAST;

EID: 16944364476     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514105     Document Type: Article

References (22)

1. Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG, zur-Hauscn H. Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 1983;80:560-3.
2. Brown DR, Bryan JT, Cramer H, Fife KH. Analysis of human papillomavirus types in exqphytic condylomata acuminata by hybrid capture and Southern blot techniques. J Clin Microbiol 1993;31:2667-73.
3. Walboomers JMM, De Roda Husman A, Van Den Brule AJC, Snijders PJF, Meijer CJL. Detection of genital human papillomavirus infections: critical review of methods and prevalence studies in relation to cervical cancer. In: Stem PL, Stanley MA, eds. Human papillomaviruses and cervical cancer. Oxford, UK: Oxford University Press, 1994:41-71.
4. Koutsky LA, Galloway DA, Holmes KK. Epidemiology of genital human papillomavirus infection. Epidemiol Rev 1988;10:122-63.
5. Kreider JW, Howett MK, Wolfe SA, et al. Morphological transformation in vivo of human uterine cervix with papillomavirus from condylomata acuminata. Nature 1985;317:639-41.
6. Kreider JW, Howett MK, Leure-Dupree AE, Zaino RJ, Weber JA. Laboratory production in vivo of infectious human papillomavirus type 11. J Virol 1987;61:590-3.
7. Christensen ND, Hopfl R, DiAngelo SL, et al. Assembled baculovirus-expressed human papillomavirus type 11 L1 capsid protein virus-like particles are recognized by neutralizing monoclonal antibodies and induce high titres of neutralizing antibodies. J Gen Virol 1994;75:2271-6.
8. Zhou J, Sun XY, Stenzel DJ, Frazer IH. Expression of vaccinia recombinant HPV-16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. Virology 1991;185:251-7.
9. Breitburd F, Kimbauer R, Hubbert NL, et al. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J Virol 1995;69:3959-63.
10. Jansen KU, Rosolowsky M, Schultz LD, et al. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 1995;13:1509-14.
11. Suzich JA, Ghim S, Palmer-Hill FJ, et al. Systemic immunization with papillomavirus L1 proteins completely prevents the development of viral mucosal papillomas. Proc Natl Acad Sci USA 1995;92:11553-7.
12. Keeper MP, Hofmann KJ, Jansen KU. Expression of the major capsid protein of human papillomavirus type 11 in Saccharomyces cerevisiae. Gene 1996;180:1-6.
13. Hofmann KJ, Cook JC, Joyce JG, et al. Sequence determination of human papillomavirus type 6a and assembly of virus-like particles in Saccharomyces cerevisiae. Virology 1995;209:506-18.
14. Christensen ND, Dillner J, Eklund C, et al. Surface conformational and linear epitopes on HPV-16 and HPV-18 L1 virus-like particles as defined by monoclonal antibodies. Virology 1996;223:174-84.
15. Carter JJ, Wipf GC, Hagensee ME, et al. Use of human papillomavirus type 6 capsids to detect antibodies in people with genital warts. J Infect Dis 1995;172:11-8.
16. Miller CJ. Animal models of viral sexually transmitted diseases. Am J Reprod Immunol 1994;31:52-63.
17. Christensen ND, Cladel NM, Reed CA. Postattachment neutralization of papillomaviruses by monoclonal and polydonal antibodies. Virology 1995;207:136-42.
18. Donnelly JJ, Martinez D, Jansen KU, Ellis RW, Montgomery DL, Liu MA. Protection against papillomavirus with a polynucleotide vaccine. J Infect Dis 1996;713:314-20.
19. Walker RI. New strategies for using mucosal vaccination to achieve more effective immunization. Vaccine 1994;12:387-400.
20. Conner ME, Crawford SE, Barone C, Estes MK. Rotavirus vaccine administered parenterally induces protective immunity. J Virol 1993;67:6633-41.
21. Marx PA, Compans RW, Gettie A, et al. Protection against vaginal SIV transmission with microencapsulated vaccine. Science 1993;260:1323-7.
22. Murphy BR. Mucosal immunity to viruses. In: Ogra P, Lamm ME, McGhee JR, Mestecky J, Strober W, Bienenstock J, eds. Handbook of mucosal immunity. San Diego: Academic Press, 1994.